Skip to main content

Table 3 Individual results of upper-limb motor capacity (FMA, ARAT), patient-reported arm usage (MAL-14, mean AOU) and daily life performance of arm activity during sitting (arm duration ratio and impaired arm duration)

From: Clinical value of assessing motor performance in postacute stroke patients

  MAL-14 (mean AOU) FMA ARAT Arm duration ratio (impaired/unimpaired) during sitting (%) Impaired arm duration (in sec) during sitting normalized per hour (sec/hour)
Patient 1 1.33 15 9 66 518
Patient 2 1.15 11 0 58 594
Patient 3 1.5 51 41 73 1107
Patient 4 0.43 9 0 56 918
Patient 5 0.93 38 28 52 546
Patient 6 1.62 62 54 94 1570
Patient 7 4.79 58 57 124 326
Patient 8 4.86 65 57 70 883
Patient 9 0.64 33 15 52 643
Patient 10 2.64 66 57 86 1346
Patient 11 4.36 66 57 89 1102
Patient 12 1.79 55 45 94 1156
Patient 13 2.14 51 46 64 873
Patient 14 0.62 11 3 67 760
Patient 15 0.54 13 2 59 640